Mutational Signatures Driven by Epigenetic Determinants Stratify Patients for Therapeutic Interventions in Gastric Cancer.
doi 10.1101/2020.04.17.20066944
Full Text
Open PDFAbstract
Available in full text
Date
April 22, 2020
Authors
Publisher
Cold Spring Harbor Laboratory